Menu ausklappen

Analyses

TheraSight® Expression Profiler

TheraSight® Expression Profiler measures the activity of all human genes (transcriptome). Based on numerous published gene expression signatures, TheraSight® Expression Profiler provides the treating oncologist with a wealth of valuable information for personalized therapeutic decisions.

TheraSight® Mutation Profiler

By TheraSight® Mutation Profiler individual patterns of therapeutically relevant mutations in important cancer-related genes are uncovered. Knowledge of a patient’s individual mutational status is indispensable for a personalized precision oncology treatment approach.

THERASIGHT® Ultraview Profiler

THERASIGHT® Ultraview Profiler, indispensable for an individualized comprehensive precision oncology treatment, is a unique state-of-the-art assay amalgamating the patient’s transcriptome data (TheraSight® Expression Profiler) and therapeutically important mutation data (TheraSight® Mutation Profiler) from Gen Mutation Panels.

zirkulierende Tumor DNA

Circulating Tumor DNA

Circulating tumor DNA (cfDNA) represents an accurate reflection of a tumor’s mutation pattern in the blood plasma. It is mostly used for real-time response monitoring to targeted drug treatment and as a surrogate analysis of a tumor’s mutational status in cases where no tumor tissue is accessible.

CTC circulating tumor cells

Circulating Tumor Cells (CTC)

The test serves to determine how the blood is affected by tumor cells. It allows for a molecular-genetic characterization of the tumor disease (real-time liquid biopsy).

Chemo-/Biopharmaceutical Sensitivity

Using isolated, living tumor cells, this test determines the response to cytotoxic and biopharmaceutical treatments.

We are happy to consult you in finding the right treatment!